PL371296A1 - Kompozycje zawiesinowe HFA zawierające antycholinergik - Google Patents

Kompozycje zawiesinowe HFA zawierające antycholinergik

Info

Publication number
PL371296A1
PL371296A1 PL03371296A PL37129603A PL371296A1 PL 371296 A1 PL371296 A1 PL 371296A1 PL 03371296 A PL03371296 A PL 03371296A PL 37129603 A PL37129603 A PL 37129603A PL 371296 A1 PL371296 A1 PL 371296A1
Authority
PL
Poland
Prior art keywords
hfa
anticholinergic
formulations containing
suspension formulations
suspension
Prior art date
Application number
PL03371296A
Other languages
English (en)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL371296(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL371296A1 publication Critical patent/PL371296A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL03371296A 2002-03-28 2003-03-20 Kompozycje zawiesinowe HFA zawierające antycholinergik PL371296A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum

Publications (1)

Publication Number Publication Date
PL371296A1 true PL371296A1 (pl) 2005-06-13

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371296A PL371296A1 (pl) 2002-03-28 2003-03-20 Kompozycje zawiesinowe HFA zawierające antycholinergik

Country Status (26)

Country Link
EP (2) EP1492513B1 (pl)
JP (1) JP4480401B2 (pl)
KR (1) KR101066801B1 (pl)
CN (1) CN1329023C (pl)
AT (1) ATE339953T1 (pl)
AU (1) AU2003209743B2 (pl)
BR (1) BR0308764A (pl)
CA (1) CA2479640C (pl)
CY (1) CY1105543T1 (pl)
DE (2) DE10214263A1 (pl)
DK (1) DK1492513T3 (pl)
EA (1) EA007239B1 (pl)
EC (1) ECSP045321A (pl)
ES (1) ES2273020T3 (pl)
HR (1) HRP20040889B1 (pl)
IL (2) IL163697A0 (pl)
ME (1) ME00247B (pl)
MX (1) MXPA04009337A (pl)
NO (1) NO20044005L (pl)
NZ (1) NZ536043A (pl)
PL (1) PL371296A1 (pl)
PT (1) PT1492513E (pl)
RS (1) RS52178B (pl)
UA (1) UA78557C2 (pl)
WO (1) WO2003082252A1 (pl)
ZA (1) ZA200405638B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101297061B1 (ko) † 2004-07-02 2013-08-19 베링거 인겔하임 인터내셔날 게엠베하 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
BR112015006571A2 (pt) * 2012-10-23 2017-07-04 Cipla Ltd composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
WO2002030928A1 (de) * 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
CA2436540C (en) * 2000-10-31 2008-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
YU85904A (sh) 2006-08-17
HK1079091A1 (en) 2006-03-31
NO20044005L (no) 2004-10-05
DE50305118D1 (de) 2006-11-02
EA200401190A1 (ru) 2005-04-28
EP1695701B1 (de) 2015-01-07
DK1492513T3 (da) 2006-12-18
ME00247B (me) 2011-05-10
MEP47408A (en) 2011-02-10
KR101066801B1 (ko) 2011-09-22
AU2003209743A1 (en) 2003-10-13
UA78557C2 (en) 2007-04-10
ATE339953T1 (de) 2006-10-15
IL163697A0 (en) 2005-12-18
NZ536043A (en) 2005-09-30
IL163697A (en) 2011-03-31
BR0308764A (pt) 2005-01-11
EP1695701A3 (de) 2010-04-28
HRP20040889A2 (en) 2004-12-31
CA2479640C (en) 2010-09-28
EP1695701A2 (de) 2006-08-30
CY1105543T1 (el) 2010-07-28
CN1329023C (zh) 2007-08-01
EA007239B1 (ru) 2006-08-25
JP4480401B2 (ja) 2010-06-16
JP2005529087A (ja) 2005-09-29
KR20040098031A (ko) 2004-11-18
MXPA04009337A (es) 2005-01-25
PT1492513E (pt) 2006-12-29
CN1642534A (zh) 2005-07-20
ECSP045321A (es) 2005-01-28
ES2273020T3 (es) 2007-05-01
ZA200405638B (en) 2005-07-27
HRP20040889B1 (hr) 2012-11-30
AU2003209743B2 (en) 2008-03-06
RS52178B (sr) 2012-10-31
CA2479640A1 (en) 2003-10-09
EP1492513B1 (de) 2006-09-20
DE10214263A1 (de) 2003-10-16
EP1492513A1 (de) 2005-01-05
WO2003082252A1 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
AU2003301516A8 (en) Antifungal formulations
IL162642A0 (en) Formulations
AU2003298738A8 (en) Liposomal formulations
AU2002366160A8 (en) Zinc-alkaline battery containing lambda-mn02
GB0217786D0 (en) Compounds
EP1275492A4 (en) PRESSURE GENERATOR
GB0207438D0 (en) Formulation
GB0323701D0 (en) Formulations
GB0205504D0 (en) Formulation
EP1503804A4 (en) RADIOPHARMACEUTICAL FORMULATIONS
HRP20040889A2 (en) Hfa-suspension formulations containing an anticholinergic
AU2003290818A8 (en) Topoisomerase-targeting agents
GB0218194D0 (en) Solid formulations
GB0307765D0 (en) Tissue-adhesive formulations
GB0210762D0 (en) Compounds
GB0214255D0 (en) Spindle
GB0207323D0 (en) Compounds
AU2003264443A8 (en) Preparation for external use
GB0216383D0 (en) Compounds
GB0214147D0 (en) Formulations
GB0213122D0 (en) Compounds
GB0213011D0 (en) Compounds
SI1492513T1 (sl) HFA-suspenzijske formulacije, ki vsebujejo antiholinergik
GB0115893D0 (en) Formulations
GB0218567D0 (en) Formulations